Mahendra Realtors Board Approves MRIL ESOP 2026, EGM Scheduled for June 11

Mahendra Realtors & Infrastructure Limited has announced that its Board of Directors, at its meeting held on Friday, May 15, 2026, considered and approved the formulation of the Employee Stock Option Plan 2026 (MRIL ESOP 2026), in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The plan is subject to the approval of shareholders at an Extra-Ordinary General Meeting (EGM) scheduled for Thursday, June 11, 2026, at 03:00 P.M. IST at the company's registered office in Mumbai. The Board also approved the notice for this meeting and appointed M/s. Sanjay Dholakia & Associates, Practicing Company Secretary, as Scrutinizer to oversee the remote e-voting process. The Board Meeting concluded at 04:00 P.M.

EGM Schedule and Voting Details

The company has established specific timelines for the EGM and the remote e-voting process. Shareholders whose names appear in the Register of Members as of the cut-off date will be eligible to participate in e-voting.

Parameter: Details EGM Date: Thursday, June 11, 2026 EGM Time: 03:00 P.M. IST Cut-off Date: Thursday, June 04, 2026 Remote E-Voting Start: Monday, June 08, 2026 (9:00 A.M. IST) Remote E-Voting End: Wednesday, June 10, 2026 (5:00 P.M. IST) Register Closure: June 04, 2026 to June 10, 2026 (both days inclusive)

Key Features of MRIL ESOP 2026

The MRIL ESOP 2026 aims to attract and retain employees by offering share-based compensation. The plan covers eligible employees of the company and its subsidiary companies. The Nomination and Remuneration Committee will act as the Compensation Committee to administer the scheme, deciding the number of options to be granted to each eligible employee. The following table outlines the key parameters of the plan:

Feature: Details Total Options: Not more than 3,00,000 (Three Lakhs) Maximum Shares on Exercise: 3,00,000 (Three Lakhs) equity shares Face Value: Rs. 10/- each, fully paid-up Minimum Vesting Period: 12 months from date of grant Maximum Vesting Period: Not more than 3 years Maximum Exercise Period: Not exceeding 6 months from Vesting Date

The exercise price will be determined by the Compensation Committee and will not be less than the face value of the equity shares (Rs. 10/-) and not more than the market price of the equity shares at the time of grant. Options will vest in line with the achievement of key organizational performance metrics, as determined by the Compensation Committee. In the event of resignation, termination, superannuation, death, or permanent disability, options will be exercised in accordance with the plan. Options that lapse due to non-exercise or employee resignation may be available for re-grant within the overall limit of 3,00,000 options.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.